Results 231 to 240 of about 32,738 (290)

Treatment of peritoneal disease arising from mucinous vs. non-mucinous appendiceal neoplasms with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

Pleura Peritoneum
Qin RX, Puloka T, Lim JH, Staheli C, Fischer J, Lolohea S, Ly J.   +6 more
europepmc   +1 more source

The predictive value of preoperative neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index for organ failure following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective analysis

Eva Borges, Miguel Sousa, Susan Marum, Mario Castro, Maria José Bouw   +4 more
openalex   +2 more sources

An Updated Meta-Analysis on Long-Term Outcomes Following Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer. [PDF]

Cancers (Basel)
El Kassis N, Jerbaka M, Abou Chakra R, El Hadi C, Arab W, El Hajj H, Brennan DJ, Atallah D.   +7 more
europepmc   +1 more source

An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. [PDF]

Ann Surg Oncol
Liu D, Chen Z, Deng W, Lan J, Zhu Y, Wang H, Xu X, Zhang Y, Wu X, Yang K, Cai J.   +10 more
europepmc   +1 more source

Challenges of Nontherapeutic Laparotomy in Patients with Peritoneal Surface Malignancies Selected for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]

Cancers (Basel)
Gil-Gómez E, González-Gil A, Olivares-Ripoll V, Cerezuela-Fernández de Palencia Á, López-Hernández F, Martínez-Espí Á, Martínez-García J, Barceló F, Guijarro-Campillo AR, Cascales-Campos PA.   +9 more
europepmc   +1 more source

Re: Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion (IHCP): Postoperative Outcome and Risk Factors for Morbidity [PDF]

, 2018
Marti, Walter
core  

A Prospective Observational Study on Compliance with Enhanced Recovery Pathways and Their Impact on Postoperative Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]

J Gastrointest Cancer
Solanki SL, Sanapala V, Ambulkar RP, Agarwal V, Saklani AP, Maheshwari A.   +5 more
europepmc   +1 more source

Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. [PDF]

J Clin Med
Kim M, Lee YJ, Seon KE, Kim S, Lee C, Park H, Choi MC, Lee JY.   +7 more
europepmc   +1 more source

Evaluating Respiratory Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Subphrenic Peritonectomy Versus Full Thickness Diaphragm Resection. [PDF]

J Surg Oncol
Liu C, Taqi K, Parapini M, MacNeill AJ, Hamilton TD.   +4 more
europepmc   +1 more source

Cytoreductive Surgery (CRS) and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) versus palliative chemotherapy in pediatric patients with peritoneal carcinomatosis (<18 years): a baseline report of a living systematic evidence synthesis

Nora Ibargoyen-Roteta, Jacinto Garcı́a, Ainhoa Jausoro, Lorea Galnares-Cordero, María Pérez Reyes   +4 more
openalex   +2 more sources